ASKA Pharmaceutical Holdings Co.,Ltd.

Tokyo Stock Exchange 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure for the year ending March 31, 2024: USD -9.60 M

ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure is USD -9.60 M for the year ending March 31, 2024, a -70.97% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure for the year ending March 31, 2023 was USD -5.62 M, a 71.24% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure for the year ending March 31, 2022 was USD -19.53 M, a -95.88% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure for the year ending March 31, 2021 was USD -9.97 M, a 52.65% change year over year.
  • ASKA Pharmaceutical Holdings Co.,Ltd. Capital Expenditure for the year ending March 31, 2020 was USD -21.05 M, a 85.15% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd.

CEO Mr. Takashi Yamaguchi
IPO Date April 1, 2021
Location Japan
Headquarters 5-1, Shibaura 2-Chome
Employees 762
Sector Consumers Staples
Industries
Description

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Similar companies

4554.T

Fuji Pharma Co., Ltd.

USD 9.11

-4.98%

4506.T

Sumitomo Pharma Co., Ltd.

USD 5.05

1.23%

4887.T

Sawai Group Holdings Co., Ltd.

USD 12.53

-1.57%

4569.T

KYORIN Holdings, Inc.

USD 9.07

-0.68%

4547.T

Kissei Pharmaceutical Co., Ltd.

USD 24.50

-0.22%

StockViz Staff

February 8, 2025

Any question? Send us an email